IL6 and inflammatory breast carcinoma: The purpose of this study was to use dynamic detection through neoadjuvant chemotherapy to assess the expression of the proangiogenic factor VEGF and the cytokine IL-6 in patients with inflammatory breast cancer, considering the main characteristics of the tumor in order to develop personalized therapy approaches.